HUWE1 Causes an Immune Imbalance in Immune Thrombocytopenic Purpura by Reducing the Number and Function of Treg Cells Through the Ubiquitination Degradation of Ets-1

Overview

Journal Front Cell Dev Biol

Specialty Cell Biology

Date 2021 Dec 13

PMID 34900980

Citations 4

Authors

Jianqin Li

Yalin Xia

Xiaoru Fan

Xiaofang Wu

Feiyun Yang

ShaoYan Hu

Zhaoyue Wang

Affiliations

Soon will be listed here.

Abstract

Immune thrombocytopenic purpura (ITP) is an autoimmune bleeding disorder and the decreased number and immunosuppressive dysfunction of Treg cells are key promoters of ITP. However, their mechanisms in ITP development have not been fully clarified. HUWE1 mRNA and protein levels in CD4 T cells in peripheral blood from ITP patients were assessed by quantitative real-time PCR and Western blot. HUWE1 function in ITP was estimated using flow cytometry, enzyme-linked immunosorbent assay and immunosuppression assay. Besides, the HUWE1 mechanism in reducing the number and function of Treg cells in ITP was investigated by immunoprecipitation, cycloheximide-chase assay, ubiquitin experiment and immunofluorescence assay. HUWE1 expression was elevated in CD4 T cells in peripheral blood from ITP patients and HUWE1 mRNA level was negatively correlated with platelet counts and Treg cell percentage. Moreover, the interference with HUWE1 increased the number of Treg cells and enhanced its immunosuppressive function, and the HUWE1 overexpression produced the opposite results. For the exploration of mechanism, HUWE1 interacted with E26 transformation-specific-1 (Ets-1) and this binding was dependent on the negative regulation of the phosphorylation level of Ets-1 (Thr38) and HUWE1 facilitated the ubiquitin degradation of Ets-1 protein to restrain Treg cell differentiation and weaken their immunosuppressive functions. The assay confirmed that the HUWE1 inhibitor alleviated ITP in mice. HUWE1 induced the immune imbalance in ITP by decreasing the number and weakening the function of Treg cells through the ubiquitination degradation of Ets-1.

Citing Articles

Xanthohumol overcomes osimertinib resistance via governing ubiquitination-modulated Ets-1 turnover.

Ma Y, Wang R, Liao J, Guo P, Wang Q, Li W Cell Death Discov. 2024; 10(1):454.

PMID: 39468027 PMC: 11519634. DOI: 10.1038/s41420-024-02220-y.

Ring1a protects against colitis through regulating mucosal immune system and colonic microbial ecology.

Wang Y, Li Q, Zhang J, Liu P, Zheng H, Chen L Gut Microbes. 2023; 15(2):2251646.

PMID: 37655448 PMC: 10478745. DOI: 10.1080/19490976.2023.2251646.

HECT, UBA and WWE domain containing 1 represses cholesterol efflux during CD4 T cell activation in Sjögren's syndrome.

Yin J, Xu J, Chen C, Ma X, Zhu H, Xie L Front Pharmacol. 2023; 14:1191692.

PMID: 37435494 PMC: 10330700. DOI: 10.3389/fphar.2023.1191692.

The giant E3 ligase HUWE1 is linked to tumorigenesis, spermatogenesis, intellectual disability, and inflammatory diseases.

Qi L, Xu X, Qi X Front Cell Infect Microbiol. 2022; 12:905906.

PMID: 35937685 PMC: 9355080. DOI: 10.3389/fcimb.2022.905906.

References

Jasek-Gajda E, Gajda M, Jasinska M, Litwin J, Lis G . TAK-733, a Selective MEK Inhibitor, Enhances Voreloxin-induced Apoptosis in Myeloid Leukemia Cells. Anticancer Res. 2018; 38(11):6147-6156. DOI: 10.21873/anticanres.12967. View

Wang Q, Li J, Yu T, Liu Y, Li K, Liu S . Disrupted balance of CD4 T-cell subsets in bone marrow of patients with primary immune thrombocytopenia. Int J Biol Sci. 2019; 15(13):2798-2814. PMC: 6909963. DOI: 10.7150/ijbs.33779. View

Ziegler S, Buckner J . FOXP3 and the regulation of Treg/Th17 differentiation. Microbes Infect. 2009; 11(5):594-8. PMC: 2728495. DOI: 10.1016/j.micinf.2009.04.002. View

Li K, Qiu C, Sun P, Liu D, Wu T, Wang K . Ets1-Mediated Acetylation of FoxO1 Is Critical for Gluconeogenesis Regulation during Feed-Fast Cycles. Cell Rep. 2019; 26(11):2998-3010.e5. DOI: 10.1016/j.celrep.2019.02.035. View

Xiang N, Li X, Li X, Wang G, Tao J, Pan H . Expression of Ets-1 and FOXP3 mRNA in CD4(+)CD25 (+) T regulatory cells from patients with systemic lupus erythematosus. Clin Exp Med. 2013; 14(4):375-81. DOI: 10.1007/s10238-013-0263-4. View

Lu G, Zhang Q, Huang Y, Song J, Tomaino R, Ehrenberger T . Phosphorylation of ETS1 by Src family kinases prevents its recognition by the COP1 tumor suppressor. Cancer Cell. 2014; 26(2):222-34. PMC: 4169234. DOI: 10.1016/j.ccr.2014.06.026. View

Zhang A, Ning B, Sun N, Wei J, Ju X . Indirubin Increases CD4+CD25+Foxp3+ Regulatory T Cells to Prevent Immune Thrombocytopenia in Mice. PLoS One. 2015; 10(11):e0142634. PMC: 4646632. DOI: 10.1371/journal.pone.0142634. View

Peter S, Bultinck J, Myant K, Jaenicke L, Walz S, Muller J . Tumor cell-specific inhibition of MYC function using small molecule inhibitors of the HUWE1 ubiquitin ligase. EMBO Mol Med. 2014; 6(12):1525-41. PMC: 4287973. DOI: 10.15252/emmm.201403927. View

Appel C, Gallego-Pedersen S, Andersen L, Blancheflor Kristensen S, Ding M, Falk S . The Src family kinase inhibitor dasatinib delays pain-related behaviour and conserves bone in a rat model of cancer-induced bone pain. Sci Rep. 2017; 7(1):4792. PMC: 5500481. DOI: 10.1038/s41598-017-05029-1. View

10.

Kirouac D, Schaefer G, Chan J, Merchant M, Orr C, Huang S . Clinical responses to ERK inhibition in -mutant colorectal cancer predicted using a computational model. NPJ Syst Biol Appl. 2017; 3:14. PMC: 5460205. DOI: 10.1038/s41540-017-0016-1. View

11.

Hao Z, Duncan G, Su Y, Li W, Silvester J, Hong C . The E3 ubiquitin ligase Mule acts through the ATM-p53 axis to maintain B lymphocyte homeostasis. J Exp Med. 2012; 209(1):173-86. PMC: 3260869. DOI: 10.1084/jem.20111363. View

12.

Yang Z, Liao J, Carter-Cooper B, Lapidus R, Cullen K, Dan H . Regulation of cisplatin-resistant head and neck squamous cell carcinoma by the SRC/ETS-1 signaling pathway. BMC Cancer. 2019; 19(1):485. PMC: 6532223. DOI: 10.1186/s12885-019-5664-7. View

13.

Moisan J, Grenningloh R, Bettelli E, Oukka M, Ho I . Ets-1 is a negative regulator of Th17 differentiation. J Exp Med. 2007; 204(12):2825-35. PMC: 2118518. DOI: 10.1084/jem.20070994. View

14.

Nikitin V, Solntseva S, Nikitin P . Protein synthesis inhibitors induce both memory impairment and its recovery. Behav Brain Res. 2018; 360:202-208. DOI: 10.1016/j.bbr.2018.11.046. View

15.

Aqrawi L, Galtung H, Guerreiro E, Ovstebo R, Thiede B, Utheim T . Proteomic and histopathological characterisation of sicca subjects and primary Sjögren's syndrome patients reveals promising tear, saliva and extracellular vesicle disease biomarkers. Arthritis Res Ther. 2019; 21(1):181. PMC: 6670195. DOI: 10.1186/s13075-019-1961-4. View

16.

Neunert C, Lim W, Crowther M, Cohen A, Solberg Jr L, Crowther M . The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood. 2011; 117(16):4190-207. DOI: 10.1182/blood-2010-08-302984. View

17.

Polansky J, Schreiber L, Thelemann C, Ludwig L, Kruger M, Baumgrass R . Methylation matters: binding of Ets-1 to the demethylated Foxp3 gene contributes to the stabilization of Foxp3 expression in regulatory T cells. J Mol Med (Berl). 2010; 88(10):1029-40. PMC: 2943068. DOI: 10.1007/s00109-010-0642-1. View

18.

Gong X, Du D, Deng Y, Zhou Y, Sun L, Yuan S . The structure and regulation of the E3 ubiquitin ligase HUWE1 and its biological functions in cancer. Invest New Drugs. 2020; 38(2):515-524. DOI: 10.1007/s10637-020-00894-6. View

19.

Singh S, Ng J, Sivaraman J . Exploring the "Other" subfamily of HECT E3-ligases for therapeutic intervention. Pharmacol Ther. 2021; 224:107809. DOI: 10.1016/j.pharmthera.2021.107809. View

20.

Ji Z, Degerny C, Vintonenko N, Deheuninck J, Foveau B, Leroy C . Regulation of the Ets-1 transcription factor by sumoylation and ubiquitinylation. Oncogene. 2006; 26(3):395-406. DOI: 10.1038/sj.onc.1209789. View